National Healthcare Corp [NHC] stock prices are down -0.56% to $137.18 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NHC shares have gain 8.74% over the last week, with a monthly amount glided 12.44%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
National Healthcare Corp [AMEX: NHC] stock has seen the most recent analyst activity on August 01, 2011, when Morgan Keegan downgraded its rating to a Mkt Perform and also revised its price target to $41 from $55. On September 23, 2008, downgrade downgraded it’s rating to Sector Perform.
The stock price of National Healthcare Corp [NHC] has been fluctuating between $89.14 and $139.64 over the past year. National Healthcare Corp [AMEX: NHC] shares were valued at $137.18 at the most recent close of the market.
Analyzing the NHC fundamentals
The National Healthcare Corp [AMEX:NHC] reported sales of 1.49B for trailing twelve months, representing a surge of 13.70% . Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.1%, and Net Profit Margin reading is 0.07%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.11 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 135.93 points at the first support level, and at 134.68 for the second support level. However, for the 1st resistance point, the stock is sitting at 139.42, and for the 2nd resistance point, it is at 141.66.
Ratios To Look Out For
It’s worth pointing out that National Healthcare Corp [AMEX:NHC]’s Current Ratio is 1.75. Also, the Quick Ratio is 1.72, while the Cash Ratio stands at 0.41. Considering the valuation of this stock, the price to sales ratio is 1.42, the price to book ratio is 2.02 and price to earnings (TTM) ratio is 21.16.
Transactions by insiders
Recent insider trading involved HASSAN EMIL E, Director, that happened on Nov 25 ’25 when 7500.0 shares were sold. CEO, Flatt Stephen Fowler completed a deal on Nov 21 ’25 to sell 1000.0 shares. Meanwhile, Director HASSAN EMIL E sold 5500.0 shares on Nov 12 ’25.
